Concepedia

N. Havrilla

NH

4

Publications

221

Citations

4

H-Index

1995

Active since

Affiliations

Seattle University(Current)

N. Havrilla is an author at Seattle University specializing in antimicrobial pharmacokinetics, drug resistance, and clinical pharmacology.

Top concepts

MedicineDrug SafetyPharmacologyDrug ResistancePharmacotherapyPharmacokineticsClinical PharmacologyAntimicrobial PharmacodynamicsAntimicrobial Pharmacokinetics

Publications per year

1995–2011

4

Publications

4

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease

Margaret L. MacMillan, Daniel Couriel, Daniel J. Weisdorf et al. · Blood · 2006 · 85 citations · Full text

Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects

Robert Cass, Carter D. Brooks, N. Havrilla et al. · Antimicrobial Agents and Chemotherapy · 2011 · 68 citations · Full text

Drug Safety, Steady State, Healthy Subjects +11

Voreloxin, a First-in-Class Anticancer Quinolone Derivative, in Relapsed/Refractory Solid Tumors: A Report on Two Dosing Schedules

Ranjana H. Advani, Herbert I. Hurwitz, Michael S. Gordon et al. · Clinical Cancer Research · 2010 · 45 citations

Plasma bactericidal/permeability-increasing protein concentrations in critically ill children with the sepsis syndrome

Hector R. Wong, Lesley Doughty, Nancy Wedel et al. · The Pediatric Infectious Disease Journal · 1995 · 23 citations

Rows per page

1–4 of 4